II. Definitions
- Apheresis
- General term describing the modification of one or several blood components (e.g. Platelets, WBCs) from a donor patient
 - Blood is separated into individual components, and one or more specific components are removed or modified
 - Remainder of the blood is then returned to donor patient after component modification
 - Apheresis is typically performed via central venous access
 
 - Plasmapheresis
- Type of Apheresis in which plasma is separated from other blood components and modified
 - Plasmapharesis may be used to remove autoantibodies, immune complexes or toxins
 - Plasmapheresis indications include Guillain Barre Syndrome and Myasthenia Gravis
 
 - Leukapheresis
- Type of Apheresis in which White Blood Cells (WBCs) are removed from a donor patient's blood
 - Remainder of the blood is returned to the donor patient
 - Leukapheresis indications (examples)
- Hyperleukocytosis (Acute Leukemia, esp. Acute Myeloid Leukemia or AML)
 - Leukostasis
 
 
 - Plasma Exchange (Platepharesis, PLEX)
- Type of Plasmapheresis in which patient donor plasma is replaced with other fluids (e.g. FFP, PPF, albumin, Dextran, saline)
 - Plasma Exchange may be used remove specific antibodies, immune complexes or toxins
 - Plasma Exchange indications (examples)
- Thrombotic Thrombocytopenic Purpura (TTP, remove Von Willebrand Factor large multimers)
 - Hyperviscosity Syndrome (remove excess Proteins)
 
 
 - Exchange Transfusion
- Type of Apheresis in which a patient's Red Blood Cells (RBCs) are replaced with a donor's RBCs
 - Exchange Transfusion indications (examples)
 
 
III. References
- Bierowski and Nyalakonda (2025) Crit Dec Emerg Med 39(6): 4-21